Related Experiment Video
Updated: Jan 9, 2026
05:46
A Proinflammatory, Degenerative Organ Culture Model to Simulate Early-Stage Intervertebral Disc Disease.
Published on: February 14, 2021
4.1K
Immune Mechanisms and Pain in Intervertebral Disc Degeneration
Haozhe Cheng1, Lice Wang1, Chuang Huang1
1Department of Orthopedics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, People's Republic of China.
Journal of Inflammation Research
|December 10, 2025
Summary
Intervertebral disc degeneration (IVDD) involves immune cells like macrophages, triggering autoimmune responses and pain. Understanding these immune mechanisms offers new targets for IVDD immunotherapies.
Area of Science:
- Immunology
- Orthopedics
- Pain Medicine
Background:
- Intervertebral disc degeneration (IVDD) is a primary cause of low back and radicular pain.
- The intervertebral disc (IVD) is considered immune-privileged, protected by physical and molecular barriers.
- Compromised barriers expose the nucleus pulposus (NP) to the immune system, initiating inflammatory processes.
Purpose of the Study:
- To review the role of autoimmunity and adaptive immunity in the progression of IVDD.
- To explore the origins of pain associated with immune system activation in IVDD.
- To highlight immune mechanisms as potential targets for novel IVDD therapies.
Main Methods:
- Literature review focusing on immunology, autoimmunity, and pain mechanisms in IVDD.
- Analysis of recent evidence on immune cell involvement, particularly macrophages.
- Synthesis of findings on immune privilege breakdown and its consequences.
Main Results:
- Immune cells, especially macrophages, play a critical role in IVDD progression.
- Exposure of NP to the immune system can trigger autoimmune responses and inflammation.
- Inflammation exacerbates dorsal root ganglion injury, leading to hyperalgesia and pain.
Conclusions:
- Immune system activation, including autoimmunity and adaptive immunity, is integral to IVDD and associated pain.
- Understanding these immune pathways is essential for developing targeted immunotherapies for IVDD.
- Future research should focus on modulating immune responses to treat IVDD and alleviate pain.
Related Concept Videos
01:44Nociception
33.0K
Nociception—the ability to feel pain—is essential for an organism’s survival and overall well-being. Noxious stimuli such as piercing pain from a sharp object, heat from an open flame, or contact with corrosive chemicals are first detected by sensory receptors, called nociceptors, located on nerve endings. Nociceptors express ion channels that convert noxious stimuli into electrical signals. When these signals reach the brain via sensory neurons, they are perceived as pain.
33.0K
01:25Analgesia and Pain Management
1.4K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
1.4K
01:28Inflammatory Response
15.8K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
15.8K